1. Nucleosome-binding protein HMGN2 exhibits antitumor activity in human SaO2 and U2-OS osteosarcoma cell lines
   GUOJUN LIANG et al, 2015, Oncology Reports CrossRef
2. Effect of HMGN2 on proliferation and apoptosis of MCF-7 breast cancer cells
   Bo Fan et al, 2018, Oncology Letters CrossRef
3. Transcriptomic analysis of peripheral blood mononuclear cells in head and neck squamous cell carcinoma patients
   Fardeela Bin‐Alee et al, 2021, Oral Diseases CrossRef
4. Prognostic Value of HMGN Family Expression in Acute Myeloid Leukemia
   Wei Cui et al, 2021, Future Oncology CrossRef
5. Multi-Omics Analysis to Characterize Cigarette Smoke Induced Molecular Alterations in Esophageal Cells
   Aafaque Ahmad Khan et al, 2020, Frontiers in Oncology CrossRef
6. Expression, tumor immune infiltration, and prognostic impact of HMGs in gastric cancer
   Zhiheng Wu et al, 2022, Frontiers in Oncology CrossRef
7. HMGN2, a new anti-tumor effector molecule of CD8+ T cells
   Lin Su et al, 2014, Molecular Cancer CrossRef
8. Increased expression of high-mobility group nucleosomal-binding domain 2 protein in various tumor cell lines
   Qian Li et al, 2018, Oncology Letters CrossRef
9. HMGN2: An Antitumor Effector Molecule of γδT Cells
   Jiao Chen et al, 2018, Journal of Immunotherapy CrossRef
10. High-mobility group nucleosome binding domain 1 (HMGN1) functions as a Th1-polarizing alarmin
    De Yang et al, 2018, Seminars in Immunology CrossRef
11. Recombinant jurkat cells (HMGN2-T cells) secrete cytokines and inhibit the growth of tumor cells
    Huanhuan Li et al, 2022, Journal of Molecular Histology CrossRef